Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Whole-Body Irradiation × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Myeloproliferative Disorders 4 Myelodysplastic Syndromes 4 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hodgkin Disease 2 Anemia, Aplastic 2 Thrombocythemia, Essential 1 Sezary Syndrome 1 Recurrence 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neoplasm, Residual 1 Mycosis Fungoides 1 Mastocytosis 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Neutrophilic, Chronic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Nuclear Medicine Department, Hospital 3 Biopsy 3 ulixertinib 2 tazemetostat 2 palbociclib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 LY3023414 2 tipifarnib 1 talazoparib 1 selpercatinib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vemurafenib 1 Temozolomide 1 Pharmacogenomic Variants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡